Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic disease drivers to target cancer. This powerful technology is designed to overcome the known bypass mechanisms of drug resistance, a common limitation of today’s precision cancer medicines. Using a novel ‘hold and kill’ mechanism, RIPTAC therapeutics target cancer cells selectively by bringing two proteins together in a tightly regulated manner, causing the loss of an essential function for cell survival and subsequent cancer cell death.
We have built a pipeline of RIPTAC therapeutics for major cancer types, uniquely addressing the unmet needs of drug resistant cancer patients, and we will continue to invent new medicines using our proprietary platform technology.
We are a bold company where collaboration, passion, and creativity thrive, all of which allows us to push the boundaries of drug discovery to identify better solutions.
Halda is proud to be a New Haven, CT based biotech, located with headquarters and state-of-the-art labs in Science Park.
Company Details
- Employees
- 46
- Address
- 115 Munson Street,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://haldatherapeutics.com/
- HQ
- New Haven, Connecticut
Halda Therapeutics Questions
Halda Therapeutics's website is https://haldatherapeutics.com/
Halda Therapeutics's LinkedIn profile is https://www.linkedin.com/company/halda-therapeutics
Halda Therapeutics has
46 employees.
View email and phone details for 46
employees at Halda Therapeutics.
Halda Therapeutics's industry is
Biotechnology Research
Halda Therapeutics's top competitors are
Evolveimmune Therapeutics,
Arvinas,
Envisagenics,
Kymera Therapeutics,
Zealand Pharma,
Anavex Life Sciences,
Cybrexa Therapeutics,
Princeton Biopartners,
Ars Pharmaceuticals, Inc.,
Actuate Therapeutics, Inc..
Halda Therapeutics's categories are Biotechnology Research
